Skip to Main Content

Paper Details

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.
Nat Med
200
2018
HIV, HIV-1, HIV-1 fusion peptide, N, envelope, guinea pigs, mice, rhesus macaques
Author NameAffiliation
Kai XuVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Cheng ChengVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Gwo-Yu ChuangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mark K LouderVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Sijy O'DellVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Reda RawiVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mallika SastryVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Chen-Hsiang ShenVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Tongqing ZhouVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Michael ChambersVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Nicole A Doria-RoseVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Aliaksandr DruzVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
S Katie FarneyVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Kathryn E FouldsVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Hui GengVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Ivelin S GeorgievVanderbilt University Medical Center, Vanderbilt University
Young Do KwonVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Thomas LemminDepartment of Pharmaceutical Chemistry, University of California San Francisco
Krisha McKeeVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John-Paul ToddVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Yaroslav TsybovskyInc., Frederick National Laboratory for Cancer Research
Yongping YangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Diana G ScorpioVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Adrian B McDermottVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lawrence ShapiroVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lawrence ShapiroColumbia University
Lawrence ShapiroColumbia University
Lawrence ShapiroVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lawrence ShapiroColumbia University
Lawrence ShapiroColumbia University
Bridget Carragher
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongColumbia University
  • 1 - 35

Datasets